Stocks TelegraphStocks Telegraph
Stock Ideas

BVS Company Profile and Key Details

NASDAQ : BVS

Bioventus Inc.

$10.68
0.03+0.28%
At Close 4:00 PM
$10.49
-0.19-1.78%
After-Market 03:59 PM
68.4
BESG ScoreESG Rating

BVS Stock Price Chart

Stock Price Today

Bioventus Inc. (BVS) stock declined over -1.78%, trading at $10.49 on NASDAQ, down from the previous close of $10.68. The stock opened at $10.35, fluctuating between $10.35 and $10.79 in the recent session.

Stock Snapshot

10.68
Prev. Close
10.35
Open
685.71M
Market Cap
65.37M
Number of Shares
10.3513
Day Low
10.79
Day High
-17.2
P/E Ratio
68.28%
Free Float in %
-0.61
EPS (TTM)
2.75
Book Value
0.13
Cash Flow per Share
131.45K
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Jan 31, 202510.6710.8310.6010.68488.7K
Jan 30, 202510.6010.8210.5010.65176.76K
Jan 29, 202510.4010.5710.2910.49201.72K
Jan 28, 202510.0910.4210.0910.42222.5K
Jan 27, 20259.8910.079.8210.06226.92K
Jan 24, 20259.9010.169.9010.03202.12K
Jan 22, 202510.2610.2810.0310.09241.6K
Jan 21, 202510.1810.3610.0410.23294.52K
Jan 17, 202510.1510.259.8510.04370.2K
Jan 16, 20259.7410.149.5610.11363.8K
Jan 15, 20258.779.778.779.71362.61K
Jan 14, 20259.189.358.848.87304.49K
Jan 13, 20259.149.258.929.16351.15K
Jan 10, 20259.309.459.199.28248.9K
Jan 08, 20259.479.629.329.58444K
Jan 07, 20259.839.909.429.55535.38K
Jan 06, 202510.4410.519.479.83487.23K
Jan 03, 202510.6210.7110.3710.44221.7K
Jan 02, 202510.8210.9010.4110.63213.2K
Dec 31, 202410.5610.6410.4010.50567.56K

Contact Details

Durham, NC 27703

United States

Website: https://www.bioventus.comContact: 919 474 6700

About Company

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Company Information

Employees1030
Beta0.88
Sales or Revenue$512.35M
5Y Sales Change%0.425%
Fiscal Year EndsDecember
SectorHealthcare
IndustryMedical - Devices

Frequently Asked Questions

What is the current Bioventus Inc. (BVS) stock price?

Bioventus Inc. (NASDAQ: BVS) stock price is $10.49 in the last trading session. During the trading session, BVS stock reached the peak price of $10.79 while $10.35 was the lowest point it dropped to. The percentage change in BVS stock occurred in the recent session was -1.78% while the dollar amount for the price change in BVS stock was -$0.19.

BVS's industry and sector of operation?

The NASDAQ listed BVS is part of Medical - Devices industry that operates in the broader Healthcare sector. Bioventus Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BVS?

Mr. Anthony D'Adamio
Senior Vice President, Gen. Counsel & Corporation Sec.
Ms. Katrina J. Church
Senior Vice President & Chief Compliance Officer
Mr. Anthony James
Vice President of Operations and Quality
Ms. Helen Leupold
Senior Vice President & Chief HR Officer
Mr. Mark Singleton
Senior Vice President, Chief Financial Officer & Principal Accounting Officer
Ms. Katrina J. Church J.D.
Senior Vice President & Chief Compliance Officer
Mr. Mark L. Singleton
Senior Vice President & Chief Financial Officer
Mr. Jeff Welch
Vice President of Bus. Devel.
Mr. Larry Chen
Managing Director of China & Asia Pacific
Mr. Kenneth M. Reali
Chief Executive Officer & Director
Mr. Leigh Ann Stradford
Senior Vice President & Chief HR Officer
Dr. Peter J. Shaw M.D.
Vice President of Medical Affairs & Chief Medical Officer
Mr. Miguel O. Beltran-Delgado
Senior Vice President of Operations
Ms. Alessandraa Pavesio
Senior Vice President & Chief Science Officer
Mr. Christopher K. Yamamoto
Senior Vice President of Corporation Devel. & Strategy
Ms. Sharon W. Klugewicz
Senior Vice President of Quality & Regulatory Affairs
Mr. Anthony P. Bihl III
Interim Chief Executive Officer & Director

How BVS did perform over past 52-week?

BVS's closing price is 173.85% higher than its 52-week low of $3.90 where as its distance from 52-week high of $14.38 is -25.73%.

How many employees does BVS have?

Number of BVS employees currently stands at 1,030.

Link for BVS official website?

Official Website of BVS is: https://www.bioventus.com

How do I contact BVS?

BVS could be contacted at phone 919 474 6700 and can also be accessed through its website. BVS operates from 4721 Emperor Boulevard, Durham, NC 27703, United States.

How many shares of BVS are traded daily?

BVS stock volume for the day was 131.45K shares. The average number of BVS shares traded daily for last 3 months was 373.42K.

What is the market cap of BVS currently?

The market value of BVS currently stands at $685.71M with its latest stock price at $10.49 and 65.37M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph